Rheumatic Disease Associates, Ltd.

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder	Recruiting	Phase 3	2026-08-27	NCT07404865
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder	Recruiting	Phase 4	2026-08-03	NCT07611214
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome	Primary Sjogrens Disease	Active, not recruiting	Phase 3	2026-04-16	NCT06684847

Clinical trials